Who Buys Clopidogrel from India — 1234 Importers Behind a $251.3M Market
India's clopidogrel import market is served by 1234 active buyers who collectively imported $251.3M across 6,037 shipments. NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) leads with a 10.2% market share, followed by AUROLOGISTICS LLC (AUROBINDO PHARMA and BELLS HEALTHCARE. The top 5 buyers together control 24.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Clopidogrel Importers — Ranked by Import Value
NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) is the leading clopidogrel importer from India, holding a 10.2% share of the $251.3M market across 6,037 shipments from 1234 buyers. The top 5 buyers — NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES), AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), BELLS HEALTHCARE (UNITED KINGDOM), AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), ALLOGA UK AP7 (UNITED KINGDOM) — collectively control 24.1% of total import value.
Top Clopidogrel Buyers & Importers
Ranked by import value · 1234 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $25.6M | 5 | 10.2% |
| 2 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $9.5M | 5 | 3.8% |
| 3 | BELLS HEALTHCAREUNITED KINGDOM CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 2X14'SPHARMACEUTICAL PRODUCTS - CLOPIDOGREL ZE | $8.8M | 5 | 3.5% |
| 4 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $8.6M | 5 | 3.4% |
| 5 | ALLOGA UK AP7UNITED KINGDOM CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 2X14'SPHARMACEUTICAL PRODUCTS - CLOPIDOGREL ZE | $8.0M | 5 | 3.2% |
| 6 | AUROLOGISTICS LLCUNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $7.5M | 5 | 3.0% |
| 7 | SYNOPTIS INDUSTRIAL SP .ZO.OPOLAND CLOPIDOGREL 75 MG TABLETS AVERELIX 75 MAVERELIX 75 MG X 28 TABL (CLOPIDOGREL 75 | $6.0M | 5 | 2.4% |
| 8 | AUROLOGISTICS LLC AUROBINDO PHARMUNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $5.2M | 5 | 2.1% |
| 9 | APL SWIFT SERVICES MALTA LTDMALTA CLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AUCLOPIDOGREL TABLETS 75MG(CLOPIDOGREL AURCLOPIDOGREL TABLETS 75MG 4X7'S (CLOPIDOG | $4.7M | 5 | 1.9% |
| 10 | APL SWIFT SERVICES (MALTA) LTD.,MALTA CLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AUCLOPIDOGREL TABLETS 75MG(CLOPIDOGREL AURCLOPIDOGREL TABLETS 75MG 4X7'S (CLOPIDOG | $4.7M | 5 | 1.9% |
| 11 | LEK D.DSLOVENIA CLOPIDOGREL 75MG TABLETSCLOPIDOGREL 75MG TABLETS (EACH TAB CONT.CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 M | $4.2M | 5 | 1.7% |
| 12 | KRKA D.D., NOVO MESTOSLOVENIA CLOPIDOGREL 75MG TABLETSCLOPIDOGREL 75MG TABLETS (EACH TAB CONT.CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 M | $4.1M | 5 | 1.6% |
| 13 | ZENTIVA PHARMA GMBHBELGIUM CLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL ARHARMLESS MEDICINES, CLOPIDOGREL/ACIDE AC | $3.9M | 5 | 1.6% |
| 14 | AUROLOGISTICS LLC(AUROBINDO PHARMAUNITED STATES CLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'SCLOPIDOGREL TABLETS 75MG CLOPIDOGREL TABLETS USP 75 MG 90'S | $3.3M | 5 | 1.3% |
| 15 | ZENTIVA ITALIA SRLITALY CLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL ARHARMLESS MEDICINES, CLOPIDOGREL/ACIDE AC | $3.2M | 5 | 1.3% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Clopidogrel — and from which countries?
Flow of Clopidogrel exports from India: each country's share and the named importers behind the numbers
Clopidogrel — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $81.3M through 488 shipments. This represents a market share of 32.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• NORTHSTAR DISTRIBUTION CENTER 8912 - $25.6M (31.5% of country's total business)
• AUROLOGISTICS LLC (AUROBINDO PHARMA - $9.5M (11.7% of country's total business)
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $8.6M (10.5% of country's total business)
• AUROLOGISTICS LLC - $7.5M (9.2% of country's total business)
• AUROLOGISTICS LLC AUROBINDO PHARM - $5.2M (6.3% of country's total business)
• Rest of United States's importers - $25.0M (30.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $166.6K, indicating premium pricing strategy compared to the market average of $41.6K.
United States is a key market for Clopidogrel imports, representing 32.3% of total trade value.
2United Kingdom
United Kingdom emerges as the second largest importing country, achieving a total trade value of $22.9M through 253 shipments. This represents a market share of 9.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• BELLS HEALTHCARE - $8.8M (38.6% of country's total business)
• ALLOGA UK AP7 - $8.0M (35.1% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $90.5K, indicating premium pricing strategy compared to the market average of $41.6K.
United Kingdom is a key market for Clopidogrel imports, representing 9.1% of total trade value.
3Cyprus
Cyprus emerges as the third largest importing country, achieving a total trade value of $12.1M through 0 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Cyprus demonstrates strong market positioning with an average shipment value of $12.1M, indicating premium pricing strategy compared to the market average of $41.6K.
Cyprus is a key market for Clopidogrel imports, representing 4.8% of total trade value.
4Slovenia
Slovenia emerges as the fourth largest importing country, achieving a total trade value of $11.6M through 58 shipments. This represents a market share of 4.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Slovenia has a diverse importer base, with their top importers including:
• LEK D.D - $4.2M (36.5% of country's total business)
• KRKA D.D., NOVO MESTO - $4.1M (35.1% of country's total business)
Key Insight: Slovenia demonstrates strong market positioning with an average shipment value of $200.4K, indicating premium pricing strategy compared to the market average of $41.6K.
Slovenia is a key market for Clopidogrel imports, representing 4.6% of total trade value.
5Malta
Malta emerges as the fifth largest importing country, achieving a total trade value of $11.5M through 307 shipments. This represents a market share of 4.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• APL SWIFT SERVICES MALTA LTD - $4.7M (40.9% of country's total business)
• APL SWIFT SERVICES (MALTA) LTD., - $4.7M (40.8% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $37.5K, indicating competitive pricing strategy compared to the market average of $41.6K.
Malta is a key market for Clopidogrel imports, representing 4.6% of total trade value.
Buyer Segment Analysis
TransData Nexus Clopidogrel buyer market intelligence
1Buyer Segment Analysis
The importers of Clopidogrel from India can be categorized into several segments:
1. Distributors: Entities that purchase Clopidogrel in bulk to supply to various healthcare providers and pharmacies. Examples include NORTHSTAR DISTRIBUTION CENTER 8912 (United States, $25.58M) and AUROLOGISTICS LLC (United States, $9.49M). These distributors typically place large, regular orders to maintain a steady supply chain for their clients.
2. Retail Chains: Pharmacy chains that import Clopidogrel directly for sale to consumers. BELLS HEALTHCARE (United Kingdom, $8.84M) is an example. Retail chains often order based on consumer demand forecasts and may adjust their purchasing patterns seasonally.
3. Re-exporters: Companies that import Clopidogrel with the intention of exporting it to other markets. APL SWIFT SERVICES MALTA LTD (Malta, $4.71M) and APL SWIFT SERVICES (MALTA) LTD. (Malta, $4.70M) fall into this category. Their buying behavior is influenced by global market demands and trade agreements.
4. Contract Manufacturers: Organizations that import Clopidogrel as an active pharmaceutical ingredient (API) for the production of finished dosage forms. SYNOPTIS INDUSTRIAL SP. ZO.O (Poland, $5.99M) is an example. Their procurement is aligned with production schedules and client contracts.
Understanding these segments helps in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Clopidogrel buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Clopidogrel from India, the import regulations are as follows:
1. United States:
2. United Kingdom:
3. Cyprus:
4. Slovenia:
5. Malta:
Compliance with these regulations is crucial for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Clopidogrel buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clopidogrel in importing countries is driven by several factors:
1. Disease Prevalence: Clopidogrel is primarily used to prevent blood clots in patients with cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2025. This high prevalence sustains the demand for antiplatelet medications like Clopidogrel.
2. Government Healthcare Programs: Many countries have implemented healthcare programs that subsidize or provide medications for chronic conditions. For instance, the United Kingdom's National Health Service (NHS) includes Clopidogrel in its formulary, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential medicines like Clopidogrel to manage non-communicable diseases. The Philippines, for example, has been enhancing its universal healthcare system, increasing access to essential medications.
4. WHO Essential Medicines List Procurement: Clopidogrel is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions to ensure the availability of critical medications.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medications through tender systems to ensure cost-effectiveness and supply stability. This approach often leads to bulk purchasing agreements for medications like Clopidogrel.
With 1,234 buyers across 137 countries, the global market for Clopidogrel remains robust, driven by the ongoing need to manage cardiovascular health effectively.
Common Questions — Clopidogrel Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest clopidogrel buyer importing from India?
Based on import volume and value, NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) leads with $25.6M in imports and a 10.2% market share — the highest of any single clopidogrel importer. AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) and BELLS HEALTHCARE (UNITED KINGDOM) are the next largest buyers.
QHow many companies buy clopidogrel from India?
There are 1234 active clopidogrel buyers importing from India, with a combined market of $251.3M across 6,037 shipments to 137 countries. The top 5 buyers hold 24.1% of total import value, while the remaining 1229 buyers handle the other 75.9%.
QWhich countries import the most clopidogrel from India?
The top importing countries for clopidogrel from India are United States (32.3%), United Kingdom (9.1%), Cyprus (4.8%), Slovenia (4.6%), Malta (4.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of clopidogrel, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for clopidogrel from India?
The average import transaction value for clopidogrel from India is $41.6K, with an average unit price of $2.24 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Clopidogrel buyer market intelligence
1Buyer Segment Analysis
The importers of Clopidogrel from India can be categorized into several segments:
1. Distributors: Entities that purchase Clopidogrel in bulk to supply to various healthcare providers and pharmacies. Examples include NORTHSTAR DISTRIBUTION CENTER 8912 (United States, $25.58M) and AUROLOGISTICS LLC (United States, $9.49M). These distributors typically place large, regular orders to maintain a steady supply chain for their clients.
2. Retail Chains: Pharmacy chains that import Clopidogrel directly for sale to consumers. BELLS HEALTHCARE (United Kingdom, $8.84M) is an example. Retail chains often order based on consumer demand forecasts and may adjust their purchasing patterns seasonally.
3. Re-exporters: Companies that import Clopidogrel with the intention of exporting it to other markets. APL SWIFT SERVICES MALTA LTD (Malta, $4.71M) and APL SWIFT SERVICES (MALTA) LTD. (Malta, $4.70M) fall into this category. Their buying behavior is influenced by global market demands and trade agreements.
4. Contract Manufacturers: Organizations that import Clopidogrel as an active pharmaceutical ingredient (API) for the production of finished dosage forms. SYNOPTIS INDUSTRIAL SP. ZO.O (Poland, $5.99M) is an example. Their procurement is aligned with production schedules and client contracts.
Understanding these segments helps in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Clopidogrel buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Clopidogrel from India, the import regulations are as follows:
1. United States:
2. United Kingdom:
3. Cyprus:
4. Slovenia:
5. Malta:
Compliance with these regulations is crucial for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Clopidogrel buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clopidogrel in importing countries is driven by several factors:
1. Disease Prevalence: Clopidogrel is primarily used to prevent blood clots in patients with cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2025. This high prevalence sustains the demand for antiplatelet medications like Clopidogrel.
2. Government Healthcare Programs: Many countries have implemented healthcare programs that subsidize or provide medications for chronic conditions. For instance, the United Kingdom's National Health Service (NHS) includes Clopidogrel in its formulary, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential medicines like Clopidogrel to manage non-communicable diseases. The Philippines, for example, has been enhancing its universal healthcare system, increasing access to essential medications.
4. WHO Essential Medicines List Procurement: Clopidogrel is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions to ensure the availability of critical medications.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medications through tender systems to ensure cost-effectiveness and supply stability. This approach often leads to bulk purchasing agreements for medications like Clopidogrel.
With 1,234 buyers across 137 countries, the global market for Clopidogrel remains robust, driven by the ongoing need to manage cardiovascular health effectively.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1234 global importers of Clopidogrel identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 6,037 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 137 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,037 Verified Shipments
1234 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists